文献速递冠心病血脂与心血管预防

冠状动脉CT血管成像指导治疗改善稳定性胸痛患者预后

Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

SCOT-HEART试验将4,146例稳定性胸痛患者随机分为标准治疗组或标准治疗+冠状动脉CTA组,冠状动脉CTA组5年冠心病死亡或非致死性心肌梗死发生率降低,且在各症状和风险亚组中效果一致;机制分析提示CTA通过优化预防性治疗 targeting 冠心病患者而改善预后。

要点

  • 稳定性胸痛患者加用冠状动脉CTA可降低5年冠心病死亡或非致死性心肌梗死风险。
  • 未诊断为冠心病所致心绞痛的患者中,CTA与较低的主要终点发生率相关。
  • CTA组预防性治疗率更高,且CT定义冠心病者治疗率最高,提示机制为优化预防治疗。

核心结论

  • 冠状动脉CTA对结局的益处在各亚组中一致,且具有合理的潜在机制。
  • 冠状动脉CTA通过使预防性治疗更好地针对冠心病患者而改善冠心病结局。

研究设计与样本

  • SCOT-HEART为开放标签试验,共纳入4,146例稳定性胸痛患者,随机接受单纯标准治疗或标准治疗+冠状动脉CTA。

主要发现

  • 主要终点事件减少在各症状和风险类别中一致(交互作用p=NS)。
  • 未诊断为冠心病所致心绞痛的患者中,冠状动脉CTA组主要终点发生率为0.23(95%CI 0.13–0.35)/100患者年,标准治疗组为0.59(95%CI 0.42–0.80)/100患者年,p<0.001。
  • 接受冠状动脉CTA者中,冠状动脉血运重建率在 first year 较高(HR 1.21;95%CI 1.01–1.46;p=0.042),1年后较低(HR 0.59;95%CI 0.38–0.90;p=0.015)。
  • 随机至冠状动脉CTA组的患者在整个随访期间预防性治疗率更高(所有p<0.001),且在CT定义冠状动脉疾病者中最高。
  • 建模研究显示观察到的效应量具有合理性。

临床怎么用

  • 对稳定性胸痛患者,可考虑冠状动脉CTA以指导冠心病诊断和预防性治疗决策。
  • 冠状动脉CTA结果可用于识别冠心病患者并加强预防性治疗,可能改善长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Within the SCOT-HEART (Scottish COmputed Tomography of the HEART Trial) trial of patients with stable chest pain, the use of coronary computed tomography angiography (CTA) reduced the rate of death from coronary heart disease or nonfatal myocardial infarction (primary endpoint). OBJECTIVES: This study sought to assess the consistency and mechanisms of the 5-year reduction in this endpoint. METHODS: In this open-label trial, 4,146 participants were randomized to standard care alone or standard care plus coronary CTA. This study explored the primary endpoint by symptoms, diagnosis, coronary revascularizations, and preventative therapies. RESULTS: Event reductions were consistent across symptom and risk categories (p = NS for interactions). In patients who were not diagnosed with angina due to coronary heart disease, coronary CTA was associated with a lower primary endpoint incidence rate (0.23; 95% confidence interval [CI]: 0.13 to 0.35 vs. 0.59; 95% CI: 0.42 to 0.80 per 100 patient-years; p < 0.001). In those who had undergone coronary CTA, rates of coronary revascularization were higher in the first year (hazard ratio [HR]: 1.21; 95% CI: 1.01 to 1.46; p = 0.042) but lower beyond 1 year (HR: 0.59; 95% CI: 0.38 to 0.90; p = 0.015). Patients assigned to coronary CTA had higher rates of preventative therapies throughout follow-up (p < 0.001 for all), with rates highest in those with CT-defined coronary artery disease. Modeling studies demonstrated the plausibility of the observed effect size. CONCLUSIONS: The beneficial effect of coronary CTA on outcomes is consistent across subgroups with plausible underlying mechanisms. Coronary CTA improves coronary heart disease outcomes by enabling better targeting of preventative treatments to those with coronary artery disease. (Scottish COmputed Tomography of the HEART Trial [SCOT-HEART]; NCT01149590).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Adamson PD, Williams MC, Dweck MR, et al. Guiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain. J Am Coll Cardiol. 2019. PMID: 31623764. doi:10.1016/j.jacc.2019.07.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。